Emergency text alerts, STEMI heart attack treatment evolution, and the race against time in cardiology procedures explained ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

In 2021, I had a heart attack in a ballroom full of people. I was in the middle of a dance—I’m a West Coast swing dancer—and ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Patients who were counseled on heart medications and lifestyle modifications by specially trained nurses were 30% less likely ...